Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Akbar Indo Makmur Stimec Tbk (AIMS) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Akbar Indo Makmur Stimec TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Akbar Indo Makmur Stimec Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Akbar Indo Makmur Stimec Tbk trades at Rp384 (market cap 86.24B, 288.2K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 3.7× Akbar Indo Makmur Stimec Tbk's market cap, and Akbar Indo Makmur Stimec Tbk is more actively traded (288.2K versus 41.7K). Which is the better fit depends on your goals.

AIMSDGNS
Market Cap
86.24B316.25B
Volume
288.2K41.7K
Lot
2.88K417
Turnover
112.41M9.66M
Average Price
390.06231.65
Value
112.41M9.66M
Indicative Equilibrium Price
384230
Indicative Equilibrium Volume
302.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AIMS
View details
DGNS
View details

About Akbar Indo Makmur Stimec Tbk

PT. Akbar Indo Makmur Tbk was established on May 7th 1997. On November 17th, 2000, PT. Stimec merged by PT. Akbar Indo Makmur and changed to be PT. Akbar Indo Makmur Stimec.

Read more on AIMS

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS